publication . Article . 2014

Cardiac Autonomic Dysfunction in Type 2 Diabetes – Effect of Hyperglycemia and Disease Duration

Mika P. Tarvainen; Mika P. Tarvainen; Tomi Petteri Laitinen; Jukka Antero Lipponen; David eCornforth; Herbert eJelinek;
Open Access English
  • Published: 01 Aug 2014 Journal: Frontiers in Endocrinology, volume 5 (eissn: 1664-2392, Copyright policy)
  • Publisher: Frontiers Media S.A.
Heart rate variability (HRV) is reduced in diabetes mellitus (DM) patients, suggesting dysfunction of cardiac autonomic regulation and an increased risk for cardiac events. The aim of this paper was to examine the associations of blood glucose level (BGL), glycated hemoglobin (HbA1c) and duration of diabetes with cardiac autonomic regulation assessed by HRV analysis. Resting electrocardiogram (ECG), recorded over 20 minutes in supine position, and clinical measurements of 189 healthy controls and 93 type 2 DM (T2DM) patients were analyzed. HRV was assessed using several time-domain, frequency-domain and nonlinear methods. HRV parameters showed a clear difference...
Persistent Identifiers
Medical Subject Headings: circulatory and respiratory physiology
free text keywords: Endocrinology, Original Research, heart rate variability, hyperglycemia, blood glucose, HbA1c, duration, cardiac autonomic neuropathy, lcsh:Diseases of the endocrine glands. Clinical endocrinology, lcsh:RC648-665, medicine.medical_specialty, medicine, Glycated hemoglobin, chemistry.chemical_compound, chemistry, Diabetes mellitus, medicine.disease, Type 2 diabetes, Heart rate, Supine position, Institutional repository, Internal medicine, Disease, business.industry, business, Cardiology
40 references, page 1 of 3

1 Berntson G Bigger J Jr Eckberg D Grossman P Kaufmann P Malik M Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology (1997) 34:623–48.10.1111/j.1469-8986.1997.tb02140.x 9401419 [OpenAIRE] [PubMed] [DOI]

2 Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability – standards of measurement, physiological interpretation, and clinical use. Circulation (1996) 93(5):1043–65.

3 Laitio T Jalonen J Kuusela T Scheinin H. The role of heart rate variability in risk stratification for adverse postoperative cardiac events. Anesth Analg (2007) 105(6):1548–60.10.1213/01.ane.0000287654.49358.3a 18042846 [OpenAIRE] [PubMed] [DOI]

4 Vinik A Maser R Mitchell B Freeman R. Diabetic autonomic neuropathy. Diabetes Care (2003) 26(5):1553–79.10.2337/diacare.26.5.1553 12716821 [OpenAIRE] [PubMed] [DOI]

5 Ewing D Borsey D Bellavere F Clarke B. Cardiac autonomic neuropathy in diabetes: comparison of measures of r-r interval variation. Diabetologia (1981) 21(1):18–24.10.1007/BF03216217 7274613 [PubMed] [DOI]

6 Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev (1994) 10(4):339–83.10.1002/dmr.5610100403 [OpenAIRE] [DOI]

7 Papanas N Vinik A Ziegler D. Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol (2011) 7:682–90.10.1038/nrendo.2011.113 21750507 [OpenAIRE] [PubMed] [DOI]

8 Kuehl M Stevens M. Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol (2012) 8:405–16.10.1038/nrendo.2012.21 22371159 [OpenAIRE] [PubMed] [DOI]

9 Khandoker A Jelinek H Moritani T Palaniswami M. Association of cardiac autonomic neuropathy with alteration of sympatho-vagal balance through heart rate variability analysis. Med Eng Phys (2010) 32:161–7.10.1016/j.medengphy.2009.11.005 20004128 [OpenAIRE] [PubMed] [DOI]

10 Acharya U Faust O Sree S Ghista D Dua S Joseph P An integrated diabetic index using heart rate variability signal features for diagnosis of diabetes. Comput Methods Biomech Biomed Engin (2013) 16(2):222–34.10.1080/10255842.2011.616945 21970360 [OpenAIRE] [PubMed] [DOI]

11 Maser R Lenhard M. Review: cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab (2005) 90(10):5896–903.10.1210/jc.2005-0754 [OpenAIRE] [DOI]

12 Abraham N Brunner E Eriksson J Robertson R. Metabolic syndrome – psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes. Ann N Y Acad Sci (2007) 1113:256–75.10.1196/annals.1391.015 17513461 [OpenAIRE] [PubMed] [DOI]

13 Vinik A Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation (2007) 115:387–97.10.1 161/CIRCULATIONAHA.106.634949 [DOI]

14 Inzucchi S Bergenstal R Buse J Diamant M Ferrannini E Nauck M Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Diabetes Care (2012) 35:1364–79.10.2337/dc12-0413 [DOI]

15 Pfeifer M Cook D Brodsky J Tice D Reenan A Swedine S Quantitative-evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes (1982) 31(4):339–45.10.2337/diab.31.4.339 7152130 [OpenAIRE] [PubMed] [DOI]

40 references, page 1 of 3
Any information missing or wrong?Report an Issue